JP2007516181A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007516181A5 JP2007516181A5 JP2006517573A JP2006517573A JP2007516181A5 JP 2007516181 A5 JP2007516181 A5 JP 2007516181A5 JP 2006517573 A JP2006517573 A JP 2006517573A JP 2006517573 A JP2006517573 A JP 2006517573A JP 2007516181 A5 JP2007516181 A5 JP 2007516181A5
- Authority
- JP
- Japan
- Prior art keywords
- immune composition
- immune
- composition
- composition according
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001282 polysaccharide Polymers 0.000 claims 10
- 239000005017 polysaccharide Substances 0.000 claims 10
- 150000004676 glycans Chemical class 0.000 claims 9
- 229960005486 vaccine Drugs 0.000 claims 5
- 102000014914 Carrier Proteins Human genes 0.000 claims 4
- 108010078791 Carrier Proteins Proteins 0.000 claims 4
- 241000991587 Enterovirus C Species 0.000 claims 4
- 201000005702 Pertussis Diseases 0.000 claims 4
- 206010043376 Tetanus Diseases 0.000 claims 4
- 206010013023 diphtheria Diseases 0.000 claims 4
- 230000003053 immunization Effects 0.000 claims 3
- 238000002649 immunization Methods 0.000 claims 3
- 241000709701 Human poliovirus 1 Species 0.000 claims 1
- 241000709704 Human poliovirus 2 Species 0.000 claims 1
- 241000709727 Human poliovirus 3 Species 0.000 claims 1
- 241000921898 Neisseria meningitidis serogroup A Species 0.000 claims 1
- IBVAQQYNSHJXBV-UHFFFAOYSA-N adipic acid dihydrazide Chemical group NNC(=O)CCCCC(=O)NN IBVAQQYNSHJXBV-UHFFFAOYSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 229960003983 diphtheria toxoid Drugs 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48092503P | 2003-06-23 | 2003-06-23 | |
| PCT/US2004/020121 WO2005000345A2 (en) | 2003-06-23 | 2004-06-23 | Immunization method against neisseria meningitidis serogroups a and c |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011004664A Division JP2011074087A (ja) | 2003-06-23 | 2011-01-13 | 髄膜炎菌血清群ａおよびｃに対する免疫方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007516181A JP2007516181A (ja) | 2007-06-21 |
| JP2007516181A5 true JP2007516181A5 (enExample) | 2007-08-16 |
Family
ID=33551955
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006517573A Pending JP2007516181A (ja) | 2003-06-23 | 2004-06-23 | 髄膜炎菌血清群ａおよびｃに対する免疫方法 |
| JP2011004664A Pending JP2011074087A (ja) | 2003-06-23 | 2011-01-13 | 髄膜炎菌血清群ａおよびｃに対する免疫方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011004664A Pending JP2011074087A (ja) | 2003-06-23 | 2011-01-13 | 髄膜炎菌血清群ａおよびｃに対する免疫方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050019337A1 (enExample) |
| EP (2) | EP1644036A2 (enExample) |
| JP (2) | JP2007516181A (enExample) |
| AU (2) | AU2004251742A1 (enExample) |
| BR (1) | BRPI0411875A (enExample) |
| CA (1) | CA2530434A1 (enExample) |
| MX (1) | MXPA05014171A (enExample) |
| WO (1) | WO2005000345A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| SI1740217T1 (sl) | 2004-04-30 | 2011-10-28 | Novartis Ag | Konjugirano meningokokno cepljenje |
| GB0500787D0 (en) | 2005-01-14 | 2005-02-23 | Chiron Srl | Integration of meningococcal conjugate vaccination |
| GB0505518D0 (en) | 2005-03-17 | 2005-04-27 | Chiron Srl | Combination vaccines with whole cell pertussis antigen |
| US9486515B2 (en) | 2005-06-27 | 2016-11-08 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
| CA2644724C (en) * | 2006-03-17 | 2016-05-24 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Methods for preparing complex multivalent immunogenic conjugates |
| US10828361B2 (en) | 2006-03-22 | 2020-11-10 | Glaxosmithkline Biologicals Sa | Regimens for immunisation with meningococcal conjugates |
| AU2007229449A1 (en) * | 2006-03-22 | 2007-10-04 | Novartis Ag | Regimens for immunisation with meningococcal conjugates |
| EP2007427A4 (en) | 2006-04-11 | 2012-04-04 | Yeda Res & Dev | IMPROVED VACCINES WITH MULTIMETER HSP60 PEPTIDE SUPPORTS |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| PL3831406T3 (pl) | 2010-08-23 | 2024-09-09 | Wyeth Llc | Stabilne preparaty antygenów rLP2086 Neisseria meningitidis |
| RU2546873C2 (ru) | 2010-09-10 | 2015-04-10 | УАЙТ ЭлЭлСи | Нелипидизированные варианты антигенов neisseria meningitidis orf2086 |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| MY167723A (en) | 2012-03-09 | 2018-09-21 | Pfizer | Neisseria meningitidis compositions and methods thereof |
| EP2852414B9 (en) | 2012-05-22 | 2020-12-09 | GlaxoSmithKline Biologicals SA | Meningococcus serogroup x conjugate |
| US9802987B2 (en) | 2013-03-08 | 2017-10-31 | Pfizer Inc. | Immunogenic fusion polypeptides |
| EP4098276A1 (en) | 2013-09-08 | 2022-12-07 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| IL312865B2 (en) | 2013-09-11 | 2025-06-01 | Eagle Biologics Inc | Liquid protein formulations containing viscosity-lowering agents |
| JP6716577B2 (ja) * | 2014-10-01 | 2020-07-01 | イーグル・バイオロジクス・インコーポレイテッドＥａｇｌｅ Ｂｉｏｌｏｇｉｃｓ， Ｉｎｃ． | 粘度低下物質を含有する、多糖および核酸の調合薬 |
| US10888611B2 (en) | 2015-02-19 | 2021-01-12 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| PE20191107A1 (es) | 2017-01-31 | 2019-08-26 | Pfizer | Composiciones de neisseria meningitidis y metodos respectivos |
| WO2021059181A1 (en) | 2019-09-27 | 2021-04-01 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356170A (en) | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4644059A (en) | 1982-07-06 | 1987-02-17 | Connaught Laboratories, Inc. | Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine |
| US4619828A (en) | 1982-07-06 | 1986-10-28 | Connaught Laboratories, Inc. | Polysaccharide exotoxoid conjugate vaccines |
| US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| US5422427A (en) | 1991-09-17 | 1995-06-06 | The United States Of America As Represented By The United States Department Of Health And Human Services | Pneumococcal fimbrial protein A |
| FR2682388B1 (fr) | 1991-10-10 | 1995-06-09 | Pasteur Merieux Serums Vacc | Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal. |
| US5445817A (en) | 1992-08-21 | 1995-08-29 | The United States Of America As Represented By The Department Of Health And Human Services | Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines |
| US5425946A (en) | 1992-08-31 | 1995-06-20 | North American Vaccine, Inc. | Vaccines against group C Neisseria meningitidis |
| US5965714A (en) * | 1997-10-02 | 1999-10-12 | Connaught Laboratories, Inc. | Method for the covalent attachment of polysaccharides to protein molecules |
| GB9806456D0 (en) * | 1998-03-25 | 1998-05-27 | Smithkline Beecham Biolog | Vaccine composition |
| US6146902A (en) | 1998-12-29 | 2000-11-14 | Aventis Pasteur, Inc. | Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| GB0108364D0 (en) * | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| OA12302A (en) * | 2000-06-29 | 2003-10-24 | Glaxosmithkline Biolog Sa | Multivalent vaccine composition. |
| EP2957300B1 (en) * | 2001-01-23 | 2021-07-14 | Sanofi Pasteur Inc. | Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| AU2002309706A1 (en) * | 2001-05-11 | 2002-11-25 | Aventis Pasteur, Inc. | Novel meningitis conjugate vaccine |
| DK1587537T3 (da) * | 2003-01-30 | 2012-07-16 | Novartis Ag | Injicerbare vacciner mod multiple meningococ-serogrupper |
-
2004
- 2004-06-23 JP JP2006517573A patent/JP2007516181A/ja active Pending
- 2004-06-23 EP EP04755949A patent/EP1644036A2/en not_active Withdrawn
- 2004-06-23 BR BRPI0411875-8A patent/BRPI0411875A/pt not_active IP Right Cessation
- 2004-06-23 WO PCT/US2004/020121 patent/WO2005000345A2/en not_active Ceased
- 2004-06-23 AU AU2004251742A patent/AU2004251742A1/en not_active Abandoned
- 2004-06-23 MX MXPA05014171A patent/MXPA05014171A/es active IP Right Grant
- 2004-06-23 EP EP10183385A patent/EP2364725A3/en not_active Withdrawn
- 2004-06-23 US US10/876,290 patent/US20050019337A1/en not_active Abandoned
- 2004-06-23 CA CA002530434A patent/CA2530434A1/en not_active Abandoned
-
2010
- 2010-11-23 AU AU2010246390A patent/AU2010246390A1/en not_active Withdrawn
-
2011
- 2011-01-13 JP JP2011004664A patent/JP2011074087A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007516181A5 (enExample) | ||
| JP2005504718A5 (enExample) | ||
| JP2004501873A5 (enExample) | ||
| JP2007516219A5 (enExample) | ||
| JP2011042693A5 (enExample) | ||
| UA92579C2 (ru) | Поливалентная менингококовая полисахаридно-белковая конъюгированная вакцина | |
| RU2378009C2 (ru) | Иммунизация против менингококков серогруппы y с помощью белков | |
| ES2707294T3 (es) | Composición inmunogénica | |
| JP2005526847A5 (enExample) | ||
| RU2006114677A (ru) | Жидкие вакцины для множественных серогрупп менингококков | |
| RU2009149359A (ru) | Состав вакцин против менингита | |
| JP2007507487A5 (enExample) | ||
| RU2008112289A (ru) | Множественная вакцинация, включающая менингококки серогруппы с | |
| JP2005508849A5 (enExample) | ||
| JP2014506916A5 (enExample) | ||
| JP2008526939A5 (enExample) | ||
| JP2005531614A5 (enExample) | ||
| DK2200642T3 (da) | Meningococvaccinepræparater | |
| RU2004136295A (ru) | Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку | |
| JP2006528936A5 (enExample) | ||
| JP2008543904A5 (enExample) | ||
| HRP20110685T1 (hr) | Cjepivo od konjugata pneumokoknog polisaharida | |
| TR201808055T4 (tr) | Kapsüler polisakaritlerin çözünürleştirilmesi ve kombinasyon aşıları. | |
| JP2021001182A5 (enExample) | ||
| EP2364725A3 (en) | Immunization method against neisseria meningitidis serogroups a and c |